Year All2026202520242023202220212020201920182017201620152014 Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member June 25, 2018 Read More ABIVAX Presents New Data on ABX464 Mechanism of Action at 16th European Meeting on HIV & Hepatitis May 31, 2018 Read More Abivax Completes Enrolment of Phase IIa Clinical Trial of ABX464 to Treat Patients with Ulcerative Colitis May 14, 2018 Read More ABIVAX announces the publication of its 2018 Registration Document April 30, 2018 Read More ABIVAX Strengthens its Management Team with the Appointment of Alexandra Pearce, Ph.D. as Vice President of Regulatory Affairs April 09, 2018 Read More 2017 Full-Year Results and Progress Report March 16, 2018 Read More ABIVAX Upcoming Events March 12, 2018 Read More ABIVAX Appoints Carol L. Brosgart, M.D. to its Board of Directors January 29, 2018 Read More ABIVAX to Initiate Long-Term Extension Study of ABX464 in Patients with Ulcerative Colitis January 04, 2018 Read More ABIVAX to Participate in “Corporate Access” Event in San Francisco, January 8 – 10, 2018 December 21, 2017 Read More
Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member June 25, 2018 Read More
ABIVAX Presents New Data on ABX464 Mechanism of Action at 16th European Meeting on HIV & Hepatitis May 31, 2018 Read More
Abivax Completes Enrolment of Phase IIa Clinical Trial of ABX464 to Treat Patients with Ulcerative Colitis May 14, 2018 Read More
ABIVAX Strengthens its Management Team with the Appointment of Alexandra Pearce, Ph.D. as Vice President of Regulatory Affairs April 09, 2018 Read More
ABIVAX to Initiate Long-Term Extension Study of ABX464 in Patients with Ulcerative Colitis January 04, 2018 Read More
ABIVAX to Participate in “Corporate Access” Event in San Francisco, January 8 – 10, 2018 December 21, 2017 Read More
